Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol. 2005 Mar; 52(3 Pt 1):425-33.